Edition:
United States

Erytech Pharma SA (ERYP.OQ)

ERYP.OQ on NASDAQ Stock Exchange Global Select Market

18.70USD
14 Dec 2017
Change (% chg)

$0.21 (+1.14%)
Prev Close
$18.49
Open
$18.84
Day's High
$18.84
Day's Low
$18.70
Volume
4,300
Avg. Vol
--
52-wk High
$30.48
52-wk Low
$18.28

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Gil Beyen

51 2013 Chairman of the Board and Chief Executive Officer

Yann Godfrin

41 2016 Deputy Chief Executive Officer, Director

Jerome Bailly

2011 Deputy Chief Executive Officer - Chief Pharmacist

Eric Soyer

2015 Chief Financial Officer, Chief Operating Officer

Thomas Vigneron

Director of Quality Assurance and Information Systems